September 2024
DDR Conference – Detection of DNA Damage Response Biomarkers in Circulating Tumour Cells using ANGLE’s Parsortix® instrument and downstream immunofluorescence assays
In this proof of concept study, we aimed to assess the performance of ANGLE's IF assays for the identification of epithelial, mesenchymal and transitioning CTCs, and to determine DDR status on the identified CTCs, by combining the use of IF with Parsortix technology.
